NPM-ALK Phosphorylates WASp Y102 and Contributes to Oncogenesis of Anaplastic Large Cell Lymphoma

Overview

Journal Oncogene

Specialties Molecular Biology
Oncology

Date 2016 Oct 4

PMID 27694894

Citations 13

Authors

C A Murga-Zamalloa

V Mendoza-Reinoso

A A Sahasrabuddhe

D Rolland

S R Hwang

S R P McDonnell

A P Sciallis

R A Wilcox

V Bashur

K Elenitoba-Johnson

M S Lim

Affiliations

Soon will be listed here.

Abstract

Mechanisms by which NPM-ALK signaling regulates cell migration, invasion and contributes to the oncogenesis of anaplastic large cell lymphoma (ALCL) are not completely understood. In an attempt to identify novel actin signaling pathways regulated by NPM-ALK, a comprehensive phosphoproteome analysis of ALCL cell lines was performed in the presence or absence of NPM-ALK activity. Numerous phosphoproteins involved in actin dynamics including Wiskott-Aldrich syndrome protein (WASp) were regulated by NPM-ALK. Network analysis revealed that WASp is a central component of the NPM-ALK-dependent actin signaling pathway. Here we show that NPM-ALK phosphorylates WASp at its known activation site (Y290) as well as at a novel residue (Y102). Phosphorylation of WASp at Y102 negatively regulates its interaction with Wiskott-Aldrich interacting protein and decreases its protein stability. Phosphorylation of WASp at Y102 enhances anchorage-independent growth and tumor growth in an in vivo xenograft model and enhances invasive properties of ALCL. We show that knock-down of WASp or expression of Y102F mutant of WASp decreases colony formation and in vivo tumor growth. Our results show that WASp is a novel substrate of ALK and has a critical role in regulating invasiveness and oncogenesis of ALCL.

Citing Articles

A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers.

Spriano F, Sartori G, Sgrignani J, Barnabei L, Arribas A, Guala M Haematologica. 2024; 109(11):3602-3614.

PMID: 38899342 PMC: 11532693. DOI: 10.3324/haematol.2022.282672.

SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target.

Carty S, Murga-Zamalloa C, Wilcox R Clin Lymphoma Myeloma Leuk. 2023; 23(8):561-574.

PMID: 37142534 PMC: 10565700. DOI: 10.1016/j.clml.2023.04.007.

NPM3 as an Unfavorable Prognostic Biomarker Involved in Oncogenic Pathways of Lung Adenocarcinoma MYC Translational Activation.

Chen L, Yang D, Huang F, Xu W, Luo X, Mei L Comb Chem High Throughput Screen. 2023; 27(2):203-213.

PMID: 37114782 DOI: 10.2174/1386207326666230419080531.

Classification and challenges in the histopathological diagnosis of peripheral T-cell lymphomas, emphasis on the WHO-HAEM5 updates.

Murga-Zamalloa C, Inamdar K Front Oncol. 2023; 12:1099265.

PMID: 36605429 PMC: 9810276. DOI: 10.3389/fonc.2022.1099265.

WASP family proteins: Molecular mechanisms and implications in human disease.

Kramer D, K Piper H, Chen B Eur J Cell Biol. 2022; 101(3):151244.

PMID: 35667337 PMC: 9357188. DOI: 10.1016/j.ejcb.2022.151244.

References

Donella-Deana A, Marin O, Cesaro L, Gunby R, Ferrarese A, Coluccia A . Unique substrate specificity of anaplastic lymphoma kinase (ALK): development of phosphoacceptor peptides for the assay of ALK activity. Biochemistry. 2005; 44(23):8533-42. DOI: 10.1021/bi0472954. View

Dupre L, Aiuti A, Trifari S, Martino S, Saracco P, Bordignon C . Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity. 2002; 17(2):157-66. DOI: 10.1016/s1074-7613(02)00360-6. View

Ramesh N, Anton I, Hartwig J, Geha R . WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. Proc Natl Acad Sci U S A. 1998; 94(26):14671-6. PMC: 25088. DOI: 10.1073/pnas.94.26.14671. View

Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos E, Condeelis J . N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors. J Cell Sci. 2012; 125(Pt 3):724-34. PMC: 3367832. DOI: 10.1242/jcs.092726. View

Morris S, Kirstein M, Valentine M, Dittmer K, Shapiro D, Saltman D . Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science. 1994; 263(5151):1281-4. DOI: 10.1126/science.8122112. View

Lane J, Martin T, Weeks H, Jiang W . Structure and role of WASP and WAVE in Rho GTPase signalling in cancer. Cancer Genomics Proteomics. 2014; 11(3):155-65. View

Lagarrigue F, Dupuis-Coronas S, Ramel D, Delsol G, Tronchere H, Payrastre B . Matrix metalloproteinase-9 is upregulated in nucleophosmin-anaplastic lymphoma kinase-positive anaplastic lymphomas and activated at the cell surface by the chaperone heat shock protein 90 to promote cell invasion. Cancer Res. 2010; 70(17):6978-87. DOI: 10.1158/0008-5472.CAN-10-0861. View

Bischof D, Pulford K, Mason D, Morris S . Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol Cell Biol. 1997; 17(4):2312-25. PMC: 232080. DOI: 10.1128/MCB.17.4.2312. View

Cougoule C, van Goethem E, Le Cabec V, Lafouresse F, Dupre L, Mehraj V . Blood leukocytes and macrophages of various phenotypes have distinct abilities to form podosomes and to migrate in 3D environments. Eur J Cell Biol. 2012; 91(11-12):938-49. DOI: 10.1016/j.ejcb.2012.07.002. View

10.

Tripathy R, McHugh R, Ghose A, Ott G, Angeles T, Albom M . Pyrazolone-based anaplastic lymphoma kinase (ALK) inhibitors: control of selectivity by a benzyloxy group. Bioorg Med Chem Lett. 2011; 21(24):7261-4. DOI: 10.1016/j.bmcl.2011.10.055. View

11.

Dovas A, Cox D . Regulation of WASp by phosphorylation: Activation or other functions?. Commun Integr Biol. 2010; 3(2):101-5. PMC: 2889963. DOI: 10.4161/cib.3.2.10759. View

12.

Zamo A, Chiarle R, Piva R, Howes J, Fan Y, Chilosi M . Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. 2002; 21(7):1038-47. DOI: 10.1038/sj.onc.1205152. View

13.

Ambrogio C, Voena C, Manazza A, Piva R, Riera L, Barberis L . p130Cas mediates the transforming properties of the anaplastic lymphoma kinase. Blood. 2005; 106(12):3907-16. PMC: 1895100. DOI: 10.1182/blood-2005-03-1204. View

14.

Badour K, Zhang J, Shi F, Leng Y, Collins M, Siminovitch K . Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation. J Exp Med. 2004; 199(1):99-112. PMC: 1887720. DOI: 10.1084/jem.20030976. View

15.

Symons M, Derry J, Karlak B, Jiang S, Lemahieu V, McCormick F . Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 1996; 84(5):723-34. DOI: 10.1016/s0092-8674(00)81050-8. View

16.

Lim M, Carlson M, Crockett D, Fillmore G, Abbott D, Elenitoba-Johnson O . The proteomic signature of NPM/ALK reveals deregulation of multiple cellular pathways. Blood. 2009; 114(8):1585-95. DOI: 10.1182/blood-2009-02-204735. View

17.

Jin P, Duan R, Luo F, Zhang G, Hong S, Chen E . Competition between Blown fuse and WASP for WIP binding regulates the dynamics of WASP-dependent actin polymerization in vivo. Dev Cell. 2011; 20(5):623-38. PMC: 3179271. DOI: 10.1016/j.devcel.2011.04.007. View

18.

de la Fuente M, Sasahara Y, Calamito M, Anton I, Elkhal A, Gallego M . WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP). Proc Natl Acad Sci U S A. 2007; 104(3):926-31. PMC: 1783416. DOI: 10.1073/pnas.0610275104. View

19.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

20.

Oda A, Ochs H, Lasky L, Spencer S, Ozaki K, Fujihara M . CrkL is an adapter for Wiskott-Aldrich syndrome protein and Syk. Blood. 2001; 97(9):2633-9. DOI: 10.1182/blood.v97.9.2633. View